Afya Ltd (STU:1AY)
€ 12 -0.20 (-1.64%) Market Cap: 1.12 Bil Enterprise Value: 1.45 Bil PE Ratio: 9.01 PB Ratio: 1.37 GF Score: 91/100

Q4 2024 Afya Ltd Earnings Call Transcript

Mar 13, 2025 / 09:00 PM GMT
Release Date Price: €14.9 (+2.05%)

Key Points

Positve
  • Afya Ltd (AFYA) reported a 14.9% increase in net revenue, reaching 34.3 million, with a 25% growth in adjusted EBITDA year over year.
  • The company achieved a record cash flow generation from operating activities, with a 34% increase compared to the previous year and a cash conversion rate of 102%.
  • Net income for 2024 reached 648.9 million, marking over 6% growth year over year, with an EPS increase of 62.9% compared to the previous year.
  • Afya Ltd (AFYA) expanded its approved medical seats by over 13% year over year, facilitated by strategic acquisitions.
  • The company announced its first dividend payout, reflecting strong cash generation and disciplined financial management.
Negative
  • The continuing education segment saw a decrease in B2B offerings by 6% over the same 12-month period of the prior year.
  • Monthly active users in the medical practice solutions segment slightly decreased from 248,000 to 238,000 due to platform transitions.
  • The company faces challenges in passing tuition fee increases above inflation, which were historically higher.
  • Afya Ltd (AFYA) is experiencing increased competition in certain regions, impacting the intake process.
  • There are regulatory concerns regarding potential monitoring of medical school prices and a proposed proficiency exam for graduating physicians.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

AFYA.OQ - Afya Ltd
Q4 2024 Afya Ltd Earnings Call
Mar 13, 2025 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Thank you for joining us for a conference call. I'm here today with ASCO Vijig Gibo and our CFO Luisareblanc.

During today's presentation, our executives will make forward-looking statements.

Forward-looking statements can be related to future events, future financial or operating performance, know and unknown risks, uncertainties, and other factors that may cause AI's actual results to differ maturely from those contemplated by these forward-looking statements.

For looking statements in this presentation include but are not limited to statements related to the business and financial performance, expectations and guidance for future periods or expectations regarding the company's strategic product initiatives and its related
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot